Elvin M Mendez MD

ALLERGY, ASTHMA & IMMUNOLOGY

Summary

Dr. Elvin Mendez is a medical specialist in Allergy and Immunology based in Port Charlotte, FL. He completed his education with an Allergy and Immunology fellowship and Pediatric residency and currently works in various roles, including Medical Director Academics, Clinical Research & Precision Medicine at Lee Health, and Allergy & Immunology at Golisano Children's Hospital of Southwest Florida. Dr. Mendez's expertise includes eosinophilic esophagitis, atopic dermatitis, urticaria, asthma, and clinical immunology. He has authored multiple publications and has received honors and awards such as Certified Principal Investigator and Fellowships from prestigious organizations like the American College of Allergy Asthma & Immunology, and the Centers for Medicare & Medicaid Services.

Eosinophilic esophagitis, Atopic dermatitis, Urticaria, Asthma, Clinical immunology, Eosinophilic gastritis, Rhinitis, Seasonal allergies, Research Asthma & COPD

Montefiore Medical Center/Albert Einstein College of MedicineFellowship, Allergy and Immunology, 1992 - 1994
Nassau University Medical CenterResidency, Pediatrics, 1989 - 1992
Universidad Nacional Pedro Henriquez UrenaClass of 1986

Certified Pricipal Investigator Academy of Clinical Research Professionals
Fellow (FACAAI) American College of Allergy Asthma & Immunology
CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012, 2014-2017

PubMed

Journal Articles

Hymenoptera reactions
Mendez EM, Sicklick MJ., Pediatr Rev., 1/1/1995
Urticaria and angioedema
Mendez EM, Sicklick MJ., Am J Asthma Allergy Pediatr., 1/1/1994

First Lee Health Research Day Highlights Innovation, TechnologyMarch 31st, 2025
Lee Health Hosts Inaugural Research Day to Showcase Medical Advancements Across the Health SystemMarch 13th, 2025
Lee Health Holds First Research Day, Including COVID-19 StudyMarch 11th, 2025

Board Member, Institutional Review Committee, Lee Health 2023 - Present
Board Member, CME Committee, Lee Health 2021 - Present
Chairman, Membership Committee, Florida Allergy, Asthma & Immunology Society 2017 - Present
Chairman, CME Committee, Lee Health 2025 - 2025
Co-Chair, Finance Committee, Florida Allergy, Asthma & Immunology Society 2024 - 2025

Principal InvestigatorRandomized, Double-blind, Double Dummy, Chronic Dosing (56 week) Placebo-controlled, Parallel Group, Multicentre, Phase III Study to Evaluate Efficacy and Safety of 3 Doses Benralizumab in Patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) with a History of COPD Exace2014 - 2016
Principal InvestigatorPhase II- A 12-week Randomized, Multiple-Dose, Double-Blind, Placebo-Controlled, Parallel-Group Study to Replicate Efficacy of Nebulized Fluticasone Propionate (FP) in Adult Subjects with Partly Controlled and Uncontrolled Asthma. (DEY Study 191-092).2012 - 2016
Principal InvestigatorPhase II- A 12-week Randomized, Multiple-Dose, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate Nebulized Fluticasone Propionate (FP)Dose Response in Adult Subjects with Partly Controlled and Uncontrolled Asthma. (DEY Study 191-091)2012 - 2016
Principal Investigator52-Week, Multicentre, Randomized, Double-Blind, Parallel Group, Placebo Controlled, Phase III Study to Evaluate Efficacy and Safety of Tralokinumab in Adults and Adolescents with Asthma Inadequately Controlled on Inhaled Corticosteroid Plus Long-Acting β2-Agonist (STRATOS2).2015 - 2015
Principal InvestigatorA Multicentre, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase III Efficacy and Safety Study of Benralizumab (MEDI-563) added to High-dose Inhaled Corticosteroid Plus Long-acting β2 Agonist in Patients with Uncontrolled Asthma (SIROCCO)2014 - 2015